Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib +/- Gemcitabine in Advanced Biliary Tract Cancer
NCT00753675Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2008
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in biliary tract cancer (BTC), sponsored by Sanofi. Started Oct 2008; status: completed.
02
Drugs
vandetanib
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00753675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753675.